Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients-Reference-Cited by-同舟云学术

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients

Published:2002-10 Issue:10 Volume:16 Page:2115-2121
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Cilloni D,Gottardi E,De Micheli D,Serra A,Volpe G,Messa F,Rege-Cambrin G,Guerrasio A,Divona M,Lo Coco F,Saglio G

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2402675.pdf

Reference23 articles.

1. Van Dongen JJ, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van Wering ER, Ludwig WD, Basso G, de Bruijn MA, Cazzaniga G, Hettinger K, van der Does-van den Berg A, Hop WC, Riehm H, Bartram CR . Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood Lancet 1998 28: 1731–1738

2. Cave H, van der Werfften Bosch J, Suciu S, Guidal C, Waterkeeyn C, Otten J, Bakkus M, Thielemans K, Grandchamp B, Vilmer E . Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group N Engl J Med 1998 27: 591–598

3. Lo Coco F, Diverio D, Falini B, Biondi A, Nervi C, Pelicci PG . Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia Blood 1999 94: 12–22

4. Diverio D, Rossi V, Avvisati G, De Santis S, Pistilli A, Pane F, Saglio G, Martinelli G, Petti MG, Santoro A, Pelicci PG, Mandelli F, Biondi A, Lo Coco F . Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARα fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter ‘AIDA’ trial. GIMEMA-AIEOP Multicenter ‘AIDA’ Trial Blood 1998 92: 784–789

5. Call KM, Glaser T, Ito CY, Bukler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH . Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus Cell 1990 60: 509–520

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of WT1 in Measurable Residual Disease Follow-Up in the Post Allogeneic Stem Cell Transplant Setting;Journal of Clinical Medicine;2024-08-30

2. Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study;Blood Cancer Journal;2024-06-13

3. Molecular alterations monitoring in myelodysplastic patients receiving an allogeneic hematopoietic stem cell transplantation after a reduced-intensity conditioning regimen;Bone Marrow Transplantation;2024-05-23

4. Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy;International Journal of Clinical Oncology;2024-02-09

5. Prognostic value of combined WT1 and multiparameter flow cytometry assessment for measurable residual disease after induction in non-APL acute myeloid leukemia;Scandinavian Journal of Clinical and Laboratory Investigation;2023-06-24